Skip to main content
. Author manuscript; available in PMC: 2009 Nov 16.
Published in final edited form as: Am J Clin Nutr. 2008 Oct;88(4):1010–1017. doi: 10.1093/ajcn/88.4.1010

TABLE 2.

Characteristics of the study group at the time of random assignment and after the crossover date on individual participants and on households (clusters)1

Baseline
After crossover
MM
(n = 249)
Placebo
(n = 251)
MM
(n = 156)
Placebo
(n = 141)
Age (y) 34.2 ± 132 34.2 ± 13 35.8 (13.9) 36.6 (13)
Male (n) 79 83 54 49
Female (n) 170 168 102 92
Education [n (%)]
 No secondary 185 (74) 193 (77) 119 (76) 107 (76)
 Any secondary 64 (26) 58 (23) 37 (24) 34 (24)
Poor housing (ie, domestic hygiene score below median) [n (%)] 83 (51) of 164 scored 86 (57) of 151 scored 47 (38) of 124 scored 38 (32) of 119 scored
BMI (kg/m2) 22.5 ± 4.4 22.5 ± 4.6 24 ± 5.5 23.2 ± 4.5
MUAC (cm) 26.7 ± 3.8 26.9 ± 3.8 28.8 ± 4 27.7 ± 3.7
HIV positive [n (%)] 69/169 tested (41) 67/191 (35) 57/134 (43) 54/124 (44)
CD4 count 370 ± 190 365 ± 212 415 ± 242 409 ± 192
Household (cluster) size3
 1 participant 49 48
 2 participants 67 67
 3 participants 10 11
 4 participants 4 4
 5 participants 4 4
1

Statistical testing of all these factors by either t test or chi-square test showed no difference in treatment allocation groups. MM, multiple micronutrient supplementation group.

2

Mean ± SD (all such values).

3

Baseline only.